ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved B...(and Res-Q as they have been able to deli...)

Date:11/5/2009

and Res-Q as they have been able to deliver high stem cell yields on a consistent basis. In addition, we have continued to enhance our quality control efforts and strengthen the management team. Our most recent additions include Jorge Artiles as Vice President, Chief Quality and Regulatory Affairs Officer, and Hal Baker as Vice President Commercial Operations. Both of these executives bring extensive major company experience and significant expertise to ThermoGenesis and will play important roles in our product quality and market expansion initiatives," he added.

Company's Conference Call and Webcast

Management will host a conference call today at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal first quarter financial results.

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. J. Melville Engle, Chief Executive Officer and Mr. Matthew T. Plavan, Executive Vice President, Chief Operating Officer and Chief Financial Officer will host the call to discuss the first quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins.

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.

Financial Statements

                                ThermoGene
'/>"/>
SOURCE  ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 
Related biology technology :

1. Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009
2. ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
3. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
4. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
5. ThermoGenesis Provides Update on Fiscal 2009 Results
6. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
7. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
8. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
9. ThermoGenesis Presentation at Rodman & Renshaw Conference
10. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
11. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device